Steven J. Charlton
University of Nottingham(GB)Max Planck Institute for Mathematics(DE)Laboratoire de Biologie Physico-Chimique des Protéines Membranaires(FR)St. John's College(US)Queen's Medical Centre(GB)Io Therapeutics (United States)(US)Receptors (United States)(US)University of Birmingham(GB)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Neuropeptides and Animal Physiology, Asthma and respiratory diseases, Advanced Mathematical Identities, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → The role of kinetic context in apparent biased agonism at GPCRs(2016)331 cited
- → Long‐lasting target binding and rebinding as mechanisms to prolongin vivodrug action(2010)282 cited
- → μ-Opioid Receptors: Correlation of Agonist Efficacy for Signalling with Ability to Activate Internalization(2010)267 cited
- → Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands(2013)230 cited
- → Extrapyramidal side effects of antipsychotics are linked to their association kinetics at dopamine D2 receptors(2017)219 cited
- → In Vitro and in Vivo Pharmacological Characterization of 5-[(R)-2-(5,6-Diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1 H-quinolin-2-one (Indacaterol), a Novel Inhaled β2 Adrenoceptor Agonist with a 24-h Duration of Action(2006)